Tim D. Werry

883 total citations
12 papers, 723 citations indexed

About

Tim D. Werry is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Tim D. Werry has authored 12 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in Tim D. Werry's work include Receptor Mechanisms and Signaling (8 papers), Adenosine and Purinergic Signaling (3 papers) and Neuropeptides and Animal Physiology (3 papers). Tim D. Werry is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Adenosine and Purinergic Signaling (3 papers) and Neuropeptides and Animal Physiology (3 papers). Tim D. Werry collaborates with scholars based in Australia, United Kingdom and Germany. Tim D. Werry's co-authors include Patrick M. Sexton, Arthur Christopoulos, Gary B. Willars, Graeme Wilkinson, Richard Loiacono, Emma T. van der Westhuizen, Roger J. Summers, Karen J. Gregory, Nanda Tilakaratne and George Christopoulos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical Journal and Endocrinology.

In The Last Decade

Tim D. Werry

12 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim D. Werry Australia 11 496 329 79 77 62 12 723
Angela Bischoff Germany 16 413 0.8× 223 0.7× 50 0.6× 47 0.6× 50 0.8× 28 662
John Mallee United States 11 385 0.8× 406 1.2× 83 1.1× 59 0.8× 29 0.5× 17 816
Valerie S. Densmore United States 7 229 0.5× 197 0.6× 63 0.8× 87 1.1× 27 0.4× 7 581
Todd L. Anthony United States 12 317 0.6× 124 0.4× 60 0.8× 43 0.6× 53 0.9× 25 614
Amy L. Clark United States 10 230 0.5× 233 0.7× 92 1.2× 82 1.1× 23 0.4× 13 513
Cristina Tinti Italy 14 394 0.8× 249 0.8× 45 0.6× 55 0.7× 14 0.2× 23 702
Camila Scorticati Argentina 14 222 0.4× 192 0.6× 52 0.7× 92 1.2× 35 0.6× 28 709
Maider López de Jesús Spain 14 322 0.6× 186 0.6× 58 0.7× 26 0.3× 21 0.3× 27 620
James Barwell United Kingdom 16 695 1.4× 637 1.9× 44 0.6× 97 1.3× 11 0.2× 20 895
Toru Fujikawa Japan 9 374 0.8× 240 0.7× 67 0.8× 32 0.4× 10 0.2× 13 709

Countries citing papers authored by Tim D. Werry

Since Specialization
Citations

This map shows the geographic impact of Tim D. Werry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim D. Werry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim D. Werry more than expected).

Fields of papers citing papers by Tim D. Werry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim D. Werry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim D. Werry. The network helps show where Tim D. Werry may publish in the future.

Co-authorship network of co-authors of Tim D. Werry

This figure shows the co-authorship network connecting the top 25 collaborators of Tim D. Werry. A scholar is included among the top collaborators of Tim D. Werry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim D. Werry. Tim D. Werry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Thomas, David R., Gareth Jones, Rudolf A. Deisz, et al.. (2010). N-desmethylclozapine (NDMC) is an antagonist at the human native muscarinic M1 receptor. Neuropharmacology. 58(8). 1206–1214. 22 indexed citations
2.
Kong, Kok Choi, Adrian J. Butcher, David Jones, et al.. (2010). M 3 -muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1. Proceedings of the National Academy of Sciences. 107(49). 21181–21186. 76 indexed citations
3.
Langmead, Christopher J., et al.. (2009). Performance of Mouse Neural Stem Cells as a Screening Reagent: Characterization of PAC1 Activity in Medium-Throughput Functional Assays. SLAS DISCOVERY. 15(2). 159–168. 2 indexed citations
4.
Werry, Tim D., et al.. (2008). Pharmacology of 5HT2C receptor-mediated ERK1/2 phosphorylation: Agonist-specific activation pathways and the impact of RNA editing. Biochemical Pharmacology. 76(10). 1276–1287. 15 indexed citations
5.
Werry, Tim D., Richard Loiacono, Patrick M. Sexton, & Arthur Christopoulos. (2008). RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacology & Therapeutics. 119(1). 7–23. 131 indexed citations
6.
Morfis, Maria, Nanda Tilakaratne, Sebastian G. B. Furness, et al.. (2008). Receptor Activity-Modifying Proteins Differentially Modulate the G Protein-Coupling Efficiency of Amylin Receptors. Endocrinology. 149(11). 5423–5431. 106 indexed citations
7.
Westhuizen, Emma T. van der, Tim D. Werry, Patrick M. Sexton, & Roger J. Summers. (2007). The Relaxin Family Peptide Receptor 3 Activates Extracellular Signal-Regulated Kinase 1/2 through a Protein Kinase C-Dependent Mechanism. Molecular Pharmacology. 71(6). 1618–1629. 72 indexed citations
8.
Werry, Tim D., Arthur Christopoulos, & Patrick M. Sexton. (2006). Mechanisms of ERK1/2 Regulation by Seven-Transmembrane-Domain Receptors. Current Pharmaceutical Design. 12(14). 1683–1702. 31 indexed citations
9.
Werry, Tim D., Karen J. Gregory, Patrick M. Sexton, & Arthur Christopoulos. (2005). Characterization of serotonin 5‐HT2Creceptor signaling to extracellular signal‐regulated kinases 1 and 2. Journal of Neurochemistry. 93(6). 1603–1615. 73 indexed citations
10.
Werry, Tim D., Graeme Wilkinson, & Gary B. Willars. (2003). Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+. Biochemical Journal. 374(2). 281–296. 147 indexed citations
11.
Werry, Tim D., Graeme Wilkinson, & Gary B. Willars. (2003). Cross Talk between P2Y2 Nucleotide Receptors and CXC Chemokine Receptor 2 Resulting in Enhanced Ca2+ Signaling Involves Enhancement of Phospholipase C Activity and Is Enabled by Incremental Ca2+ Release in Human Embryonic Kidney Cells. Journal of Pharmacology and Experimental Therapeutics. 307(2). 661–669. 20 indexed citations
12.
Werry, Tim D., Mark Christie, Ian Dainty, Graeme Wilkinson, & Gary B. Willars. (2002). Ca2+ signalling by recombinant human CXCR2 chemokine receptors is potentiated by P2Y nucleotide receptors in HEK cells. British Journal of Pharmacology. 135(5). 1199–1208. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026